AGT and hypertensive disorder: In a mouse model of hypertension generated using Angiotensin II (ANGII), Choi et al. (2015) demonstrated that the HDAC6 selective inhibitor (Tubastatin A) combined with a Smad3 knockdown inhibited TGF-β and ANG-induced renal fibrosis.